Меню
Идёт набор NCT07179536

Time to Ambulation After ProGlide Closure

Без фазы С лечением Femoral Access Site Closure Ambulation Vascular Access Complication Vascular Access Site Management

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Ambulation after ProGlide Closure.
Кому может быть актуально
Состояния в реестре: Femoral Access Site Closure, Ambulation, Vascular Access Complication, Vascular Access Site Management. Базовые параметры: 18 лет — 75 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Китай
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Optimizing Time to Ambulation After ProGlide Closure of Femoral Access: A Randomized Controlled Trial

Обзор

Transradial access has become the standard for coronary procedures due to fewer vascular complications and shorter bed rest, yet transfemoral access remains essential for complex peripheral interventions requiring larger sheaths and stronger support. Vascular closure devices (VCDs), particularly suture-mediated devices such as ProGlide, have improved femoral access by reducing hemostasis time, ambulation delay, and patient discomfort. Although early ambulation after ProGlide closure has been reported, current practice varies widely, and the relationship between ambulation timing and vascular complications remains unclear. This trial aims to evaluate the effect of different ambulation times after ProGlide closure in transfemoral peripheral angiography or intervention, with the goal of identifying the optimal time to ambulation that balances safety and efficiency.

Подробное описание

Transradial access has replaced transfemoral access as the mainstream approach for coronary angiography and intervention due to its lower incidence of vascular complications and shorter postoperative bed rest. In non-coronary endovascular interventions, radial access is also an attractive alternative. However, the traditional femoral approach retains irreplaceable advantages: it is easier for puncture and sheath insertion, accommodates sheaths ≥ 8F, allows the delivery of larger stents, provides better guiding catheter support, and reduces procedural difficulty and time.

In recent years, the widespread use of vascular closure devices (VCDs) has further improved the physician and patient experience of femoral access. Compared with manual compression, VCDs significantly reduce hemostasis time, shorten postoperative bed rest, and improve patient comfort and satisfaction. VCDs can be classified into four categories based on the closure mechanism: collagen plug, suture-mediated, disc-based, and metal clip. Although comparative studies among different VCDs are limited, the efficacy and safety of suture-mediated VCDs have been well demonstrated. ProGlide, as a representative of suture-mediated VCDs, is favored for large sheath compatibility, reliable hemostasis, and low vascular complication rates.

Evidence from Aravind Sekhar et al. showed that patients undergoing diagnostic coronary angiography via femoral access could ambulate early after ProGlide closure, which is a key driver for reducing hospitalization time, lowering costs, and improving patient satisfaction. While previous studies have reported the benefit of VCDs in shortening time to ambulation, the determination of ambulation time was largely empirical, ranging from 2 to 12 hours depending on operator experience. Currently, there is a lack of evidence regarding the association between ambulation time and vascular complications at the access site. This study aims to investigate the impact of different ambulation times after ProGlide closure in patients undergoing transfemoral peripheral angiography or endovascular intervention on vascular access site complications, in order to determine the optimal timing for ambulation.

Вмешательства

  • Процедура Ambulation after ProGlide Closure
    Ambulation time after femoral artery access site closure using the ProGlide vascular closure device was assigned to 2 hours, 6 hours, or 12 hours post-procedure.

Первичные конечные точки

  • Incidence of Femoral Access Site Vascular Complications [Срок оценки: Within 24 hours post-procedure or before hospital discharge (whichever comes first)]
Вторичные конечные точки (3)
  • Ankle-Brachial Index (ABI) Changes [Срок оценки: Before discharge]
  • Pain at Access Site (Visual Analog Scale, VAS) [Срок оценки: 24 hours post-procedure]
  • Vascular Complications within 30 Days [Срок оценки: 30 days post-procedure]

Критерии участия

Критерии включения

  • Scheduled for peripheral angiography or endovascular intervention via transfemoral access.
  • Femoral artery puncture site located at the common femoral artery.
  • Use of 6-8F vascular sheath.
  • Hemostasis achieved with 6F ProGlide closure device (defined as no active bleeding, no hematoma formation, and no ischemia of the punctured limb after closure).
  • Preoperative ankle-brachial index (ABI) > 0.9 on both sides.
  • Conscious, cooperative, and with normal lower limb mobility.

Критерии исключения

  • Undergoing carotid artery intervention.
  • Femoral artery diameter < 5 mm, or effective lumen < 5 mm due to plaque burden.
  • History of vascular complications at the puncture site.
  • Abnormal cardiopulmonary function.
  • Intraoperative platelet count < 80 × 10⁹/L, or use of thrombolytic agents.
  • Cognitive impairment, uncooperative, or limited lower limb mobility.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Поддерживающая терапия

Центры проведения

Китай · 1 центр
  • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sci — Пекин

Идентификаторы

NCT: NCT07179536 · 2025-0906

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗